JAN 28, 2015 12:00 AM PST

Bad Luck May Play Key Role in Cancer Developing in Some Tissues: Researchers unravel why certain tissues spur cancers more frequently than other types

WRITTEN BY: Judy O'Rourke
Why does cancer flourish more often in certain tissue (in the colon, say) than in others (bone)? Random mutations, which happen in normal, dividing stem cells may be the key culprit for this striking variation, impacted less so by hereditary and environmental cues, according to researchers.

Cristian Tomasetti, PhD, assistant professor, Division of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, and Bert Vogelstein, MD, Clayton Professor of Oncology and Pathology, director, Ludwig Center for Cancer Genetics & Therapeutics, The Johns Hopkins Kimmel Cancer Center, found a solid association between the number of typical stem cell divisions in a tissue in a person's lifetime and the rate that cancer occurred in that tissue.

"While there are, of course, many cancers where primary prevention has huge positive effects-such as vaccines against infectious agents, quitting smoking, or other altered lifestyles-our analysis seems to indicate that, for many other cancers, primary prevention may not be as effective overall," Tomasetti says. "However, this does not imply at all that there is not much we can do to prevent those cancers. It just highlights the importance of secondary prevention, such as early detection. We should probably focus more resources and research on finding ways to detect cancer at early, curable stages."

The startling finding that "bad luck" is such a big factor in cancer developing in different tissues could have a plus, in that it may allow researchers to devise successful strategies to thwart the various cancer types.

The researchers' initial plan was to yank the "bad luck" element from the mix and concentrate on the role of other two elements, but they discovered that just one-third of the variation in cancer occurrence in tissues was spurred by both inherited predisposition and the environment.

The findings, published in an article titled "Variation in cancer risk among tissues can be explained by the number of stem cell divisions" in the journal Science, are found here: bit.ly/154tfsa

"In many tissues, there is a hierarchy of cells-some live for a long time and keep a tissue in equilibrium by producing other, more specialized cells, which only live for a few days or weeks," Tomasetti says. "We thought it was important to focus only on the long-lived type of cells-the stem cells-that will carry over mistakes if and when they are made, by transferring them to their progeny."

Tomasetti says it is not only about how many stem cells there are. "It's also about how many times they divide. When you combine these values, you can estimate how many of these 'risky' mutation events happen," he says.

Image: Two-thirds of the variation in cancer incidence can be explained by the ‘bad luck' of mutations that occur during stem cell division.
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
JUN 26, 2018
Cancer
JUN 26, 2018
Five "-omics" Fields Introduced
An introduction to genomics, transcriptomics, proteomics, epigenomics, and metabolomics....
JUL 03, 2018
Cancer
JUL 03, 2018
Hereditary Myeloid Neoplasm Predisposition
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mutations predisposing family members to myeloid neoplasms in adulthood....
JUL 24, 2018
Cancer
JUL 24, 2018
Transfection, Transduction, and CRISPR...Oh My
CRISPR gene editing came about based on transfection and transduction type models of genetic transfer. There is potential for it to revolutionize gene editing but are there dangers lurking?...
JUL 31, 2018
Cancer
JUL 31, 2018
Can Medicine Prevent Cisplatin-associated Hearing Loss for Pediatric Cancer Patients?
Researchers have determined that sodium thiosulfate's antioxidant properties can prevent hearing loss in pediatric cancer patients being treated with Cisplatin....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
AUG 30, 2018
Genetics & Genomics
AUG 30, 2018
Genetic Changes can Help Diagnose Childhood Cancers Far Earlier
New research has revealed genetic rearrangements that happen far before bone cancer starts growing in children....
Loading Comments...